Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nephrosolid for Urinary Output Stimulation
NCT04338477Phase 3Completed
- Sponsor
- A.Vogel
- Start
- Feb 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in Urinary System Diseases ((none)) and nephrolithiasis, sponsored by A.Vogel. Primary endpoint: Tolerability as assessed by the treating physician at Day 29. Started Feb 2018; status: completed.
02
Conditions
Urinary System Diseases ((none))nephrolithiasis
Beyond the preview
Go deeper on NCT04338477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338477.